New York
New York
212-643-8811 ext. 327 121 West 36th Street #201 New York, NY 10018

Category

Notes & Papers
When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Continue Reading
When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Continue Reading
When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Continue Reading
When Shatterproof launched its new ATLAS (Addiction Treatment Locator, Assessment, and Standards Platform) project, funded largely by insurance companies, as a pilot in six states, opioid treatment programs (OTPs) of New York State said yes, they want to participate. The reason is not because OTPs are interested in having disgruntled patients post complaints in a...
Continue Reading
Covid-19 has made life much harder for people with opioid addiction. But the response to the virus has also revealed a way forward that could radically expand effective treatment and reduce overdose deaths.communities from the scourge of opioid addiction. Additionally, the Senate Majority released a report generated by the Joint Senate Task Force on Opioids,...
Continue Reading
Since March, when the Substance Abuse and Mental Health Services Administration (SAMHSA) relaxed rules for methadone take-homes to decrease exposure to the coronavirus, opioid treatment programs (OTPs) have been exercising this unprecedented freedom. Specifically, SAMHSA said March 16 that all states with declared states of emergency may request blanket exemption (from SAMHSA) for all stable...
Continue Reading
When New York State closed all essential businesses in late March, it left millions of people with questions about how to get medication without putting themselves at risk for COVID 19. That includes the nearly 30,000 people who receive methadone to treat opioid addiction across New York City, 15,000 of whom will have to isolate...
Continue Reading
For the 30,000 patients who take methadone every day for opioid use disorder in New York City, one big worry was potentially taken away this week. If they are not able to get to their opioid treatment program (OTPs, commonly known as methadone clinics) because they are quarantining with COVID-19 or symptoms of it, they...
Continue Reading
When COVID-19 hit the U.S., public health professionals were already busy battling another epidemic – the drug crisis in this country. President Trump announced Wednesday that the nation will launch enhanced counter-narcotics operations in the Western Hemisphere to prevent drug cartels from exploiting the coronavirus pandemic.
Continue Reading
1 2 3 4